FindTrial
Sign In

Effect of Homoeopathic Medicine Kali Arsenicosum 30C in Children with Atopic Dermatitis

A Study to Assess the Utility of Homoeopathic Medicine Kali Ars 30C on Reducing Symptoms Severity of Atopic Dermatitis in Children using SCORAD SCORE index - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113779
Enrollment
34
Registered
2026-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Kali Arsenicosum 30C: Duration - 2 Weeks Frequency - 3 Pills Morning and Night Route of Administration - Oral Control Intervention1: Nil: Nil

Sponsors

FATHER MULLER HOMOEOPATHIC MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both Male and Female Sex 2. Age Group from 4 to 16 Years of Age Children 3. Diagnosed With Atopic Dermatitis According to Hanifin and Rajka Criteria 4. SCORAD Severity Interpretation Under, Mild less than 25 AND Moderate 25 TO 50 Range will be included

Exclusion criteria

Exclusion criteria: 1. PATIENTS WHO ARE ON TOPICAL APPLICATIONS WILL BE EXCLUDED 2. ANY SKIN FUNGAL INFECTION 3. PATIENT WITH ASTHMA, ALLERGIC RHINITIS WILL BE EXCLUDED

Design outcomes

Primary

MeasureTime frame
Effect of Homoeopathic Medicine Kali Ars 30C in Reducing the Severity of Atopic Dermatitis in ChildrenTimepoint: Baseline, 2 Weeks, 4 Weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDR RESHEL NORONHA

FATHER MULLER HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

reshel.noronha@gmail.com9986789627

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026